In general, the earlier the cancer is diagnosed the more effective the treatments are at preventing recurrence of breast cancer.

Researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), reporting this week in the journal Proceedings of the National Academy of Sciences, identified a mechanism through which two antiviral genes, when mutated, promote a childhood cancer called pediatric myelodysplastic syndrome (MDS). Scientists at Oklahoma State University and Cornell University collaborated […]

Heidi Ko, MD, joins our breast oncology team as an assistant professor focusing on breast medical oncology. Dr. Ko received her medical degree from Rowan University School of Osteopathic Medicine in Stratford, New Jersey. She completed her residency in internal medicine at McGovern Medical School at The University of Texas Health Science Center at Houston. […]

Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – The cardio-oncology program at The University of Texas Health Science Center at San Antonio has been recognized by the International Cardio-Oncology Society as a Center of Excellence, reflecting its exceptionally high level of expertise in cardiovascular care of cancer patients and survivors. Cardio-oncology is a quickly developing […]

Advancing the Science of Cancer in Latinos event set for Feb. 23-25 Media contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu On-site contact: Cliff Despres, (210) 562-6517, despres@uthscsa.edu Written by Cliff Despres, Institute for Health Promotion Research, UT Health San Antonio SAN ANTONIO — With one in three Latinos facing a cancer diagnosis in their lifetime, UT […]

First lady Jill Biden toured Mays Cancer Center at UT Health San Antonio and praised its efforts in addressing disparities in cancer rates among Latinos.

Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – First lady Jill Biden toured Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), and praised its efforts in addressing disparities in cancer rates among Latinos. The visit came on the same day as the opening of the […]

The FDA has approved pacritinib for myelofibrosis patients with low platelet counts. Investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, played a lead role in gaining U.S. Food and Drug Administration approval of pacritinib to treat the chronic leukemia known as myelofibrosis. The FDA granted accelerated approval of the […]

An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio, together with SignalRx Pharmaceuticals Inc., have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division chief of hematology and medical oncology at UT […]